{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-21-035774","form_type":"8-K","ticker":"CYCN","cik":"0001755237","company_name":"Cyclerion Therapeutics, Inc.","filed_at":"2021-10-28T23:59:59+00:00","discovered_at":"2026-05-14T18:04:13.953465+00:00","generated_at":"2026-06-28T16:54:25.254905+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Cyclerion appoints CEO Peter Hecht as interim CFO during CFO's maternity leave","bullets":["Peter M. Hecht, CEO, appointed Interim CFO effective October 27, 2021 while Anjeza Gjino is on maternity leave.","Upon Ms. Gjino's return, she will resume her CFO role and Dr. Hecht will return to CEO duties.","Other officers have assumed some of Ms. Gjino's responsibilities during her absence."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-21-035774","json":"https://secwatch.observer/filing/0001140361-21-035774.json","markdown":"https://secwatch.observer/filing/0001140361-21-035774.md","text":"https://secwatch.observer/filing/0001140361-21-035774.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1755237/000114036121035774/0001140361-21-035774-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1755237/000114036121035774/brhc10030191_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T16:54:25.254905+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8e5477ce82","claim":"Peter M. Hecht was appointed as Interim Chief Financial Officer at Cyclerion Therapeutics, Inc..","evidence_excerpt":"On October 27, 2021, the Board of Directors of Cyclerion Therapeutics, Inc. (the “Company”) temporarily appointed Peter M. Hecht, Ph.D., as Interim Chief Financial Officer (principal financial and accounting officer) of the Company while Anjeza Gjino is on maternity leave.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1755237/000114036121035774/0001140361-21-035774-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"temporarily appointed"},{"label":"Role","value":"Interim Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}